Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Passion is an important word in Georgina Long’s lexicon. It’s the drive that has stamped her as an internationally renowned ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

A breast cancer vaccine targeting a key protein showed strong immune responses in over 75 percent of its trial participants ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Following 18 years of effort, the domestically developed 9-valent HPV vaccine has demonstrated trial data comparable to that of imported ones.

Falling vaccination rates could lead to the return of previously eliminated diseases, and many more people will be at risk of ...

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising ...

In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...

Kennedy Jr. and the Make America Healthy Again movement marched through that rift as they rose to power. As secretary of ...